Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase

来源 :药学学报(英文版) | 被引量 : 0次 | 上传用户:ashwgs
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become one major threat to human population health.The RNA-dependent RNA polymerase (RdRp) presents an ideal target of antivirals,whereas nucleoside analogs inhibitor is hindered by the proofreading activity of coronavirus.Herein,we report that corilagin (RAI-S-37) as a non-nucleoside inhibitor of SARS-CoV-2 RdRp,binds directly to RdRp,effectively inhibits the polymerase activity in both cell-free and cell-based assays,fully resists the proofreading activity and potently inhibits SARS-CoV-2 infection with a low 50% effective concentration (EC50) value of 0.13 μmol/L.Computation modeling predicts that RAI-S-37 lands at the palm domain of RdRp and prevents conformational changes required for nucleotide incorporation by RdRp.In addition,combination of RAI-S-37 with remdesivir exhibits additive activity against anti-SARS-CoV-2 RdRp.Together with the current data available on the safety and pharmacokinetics of cor-ilagin as a medicinal herbal agent,these results demonstrate the potential of being developed into one of the much-needed SARS-CoV-2 therapeutics.
其他文献
Macrophages are typically identified as classically activated (M1) macrophages and alterna-tively activated (M2) macrophages,which respectively exhibit pro-and anti-inflammatory phenotypes,and the balance between these two subtypes plays a critical role i
Limb and CNS expressed 1 like (LIX1L) is over-expressed in several types of tumors.How-ever,the function of LIX1L in glucose metabolism and hepatocellular carcinoma (HCC) progression re-mains elusive.Here we report that LIX1L is over-expressed in human HC
Fusidane-type antibiotics,represented by helvolic acid,fusidic acid and cephalosporin P1,are fungi-derived antimicrobials with little cross-resistance to co mmonly used antibiotics.Generation of new fusidane-type derivatives is therefore of great value,bu
Remdesivir (RDV) is the only US Food and Drug Administration (FDA)-approved drug for treating COVID-19.However,RDV can only be given by intravenous route,and there is a pressing medical need for oral antivirals.Significant evidence suggests that the role
Obesity and its associated complications are highly related to a current public health crisis around the world.A growing body of evidence has indicated that G-protein coupled bile acid (BA) re-ceptor TGR5 (also known as Gpbar-1) is a potential drug target
The bromodomain and extraterminal(BET)family member BRD4 is pivotal in the pathogen-esis of cardiac hypertrophy.BRD4 induces hypertrophic gene expression by binding to the acetylated chromatin,facilitating the phosphorylation of RNA polymerases Ⅱ(Pol Ⅱ)an
Acute myeloid leukaemia (AML) is the most common form of acute leukaemia in adults,with increasing incidence with age and a generally poor prognosis.Almost 20% of AML patients express mutant isocitrate dehydrogenase 2 (mIDH2),which leads to the accumulati
Traditional Chinese medicine (TCM) has been an indispensable source of drugs for curing various human diseases.However,the inherent chemical diversity and complexity of TCM restricted the safety and efficacy of its usage.Over the past few decades,the comb
The dose-related adverse effects of MDM2-P53 inhibitors have caused significant concern in the development of clinical safe anticancer agents.Herein we report an unprecedented homo-PROTAC strategy for more effective disruption of MDM2-P53 interaction.The
Leading by cytotoxicity against HepG2 cells,bioactivity-guided fractionation of the EtOAc fraction from Artemisia atrovirens led to the isolation of 18 new guaianolide dimers,artematrolides A--R and lavandiolides A,B,C,H,and J.Eight compounds (1,4,10,12,1